Australia's largest stock trading and investment forum Australia's #1 stock forum

NEURIZON THERAPEUTICS LIMITED

13.6%

12.5¢

Market Cap $61.53M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NUZ ANNOUNCES STRONG RESULTS IN LATEST STUDY

Latest Threads

Tag

Subject

NUZ -- New Investor thread

19 20 21

23/04/25

1.2K

373K

23/04/25

Last post pi065509

1.2K

373K

Ann: Appointment of Chief Financial Officer

23/04/25

18

4.1K

23/04/25

Last post NZ Trader

18

4.1K

Ann: Leadership team strengthened with strategic appointments

20/04/25

32

10K

20/04/25

Last post Peeteepoo

32

10K

Neurizon strengthens leadership team with strategic appointments

17/04/25

0

280

17/04/25

Last post Van1

0

280

Ann: NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells

2

16/04/25

64

16K

16/04/25

Last post kpax

64

16K

Neurizon Therapeutics announces strong safety results in latest study

14/04/25

0

329

14/04/25

Last post ASX Insights

0

329

Ann: NUZ-001 Shows Positive Results in Human 3D Brain Model

07/04/25

44

10K

07/04/25

Last post Quiltman

44

10K

Stratification "solutions" Healey Platform

04/04/25

16

4.5K

04/04/25

Last post coads

16

4.5K

TOP 100 NUZ SHAREHOLDERS AS AT 31/03/25

01/04/25

0

536

01/04/25

Last post RAN58

0

536

TOP 100 NUZ OPTION HOLDERS 31 MARCH 2025

01/04/25

0

372

01/04/25

Last post RAN58

0

372

Neurizon finds positive results for lead drug in 3D brain model study

01/04/25

0

318

01/04/25

Last post ASX Insights

0

318

Ann: NUZ-001 shows promising respiratory outcome

2

29/03/25

71

18K

29/03/25

Last post Van1

71

18K

Ann: Neurizon Commences Initiatives to Lift Clinical Hold

2 3

25/03/25

120

29K

25/03/25

Last post coads

120

29K

Owners help line

08:17

9

2.4K

08:17

Last post Ace101

9

2.4K

Strathmin2 the Holy Grail or cream on the cake?

18/03/25

13

4.8K

18/03/25

Last post NZ Trader

13

4.8K

Ann: Neurizon updates on NUZ-001 IND Application

6 7 8

17/03/25

434

133K

17/03/25

Last post NZ Trader

434

133K

See All Discussions

Corporate Spotlight

ABOUT NEURIZON

Timeline

Appointment of Chief Financial Officer
22 Apr 09:28	Share

Leadership team strengthened with strategic appointments
17 Apr 09:22	Share

NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
04 Apr 12:07	Share

NUZ-001 Shows Positive Results in Human 3D Brain Model
01 Apr 09:03	Share

NUZ-001 shows promising respiratory outcome
24 Mar 09:47	Share

Neurizon Commences Initiatives to Lift Clinical Hold
17 Mar 09:22	Share

Appendix 4D - Half-year Financial Report - 31 December 2024
17 Feb 14:28	Share

Neurizon to Present Latest Results and Key Updates
17 Feb 09:27	Share

FDA Guidance on NUZ-001 IND Application
17 Feb 09:14	Share

Notice of Company Update Webinar
11 Feb 14:29	Share

Change of Director's Interest Notices x3
07 Feb 09:58	Share

US Patent granted for NUZ-001
05 Feb 09:18	Share

Notification regarding unquoted securities - NUZ
31 Jan 16:46	Share

Appendix 4C & Quarterly Update
29 Jan 09:14	Share

Neurizon updates on NUZ-001 IND Application
17 Jan 09:59	Share

Change of Share Registry
16 Jan 08:19	Share

Section 708A Cleansing Statement
27 Dec 17:07	Share

Application for quotation of securities - NUZ
27 Dec 17:00	Share

Neurizon Files IND Application to Support HEALEY ALS Trial
18 Dec 09:13	Share

Neurizon Granted OMPD for NUZ-001 in Europe
17 Dec 08:52	Share

Positive 8-month Interim Data from OLE Study
16 Dec 09:34	Share

Neurizon Presents Company Update and 2025 Outlook
12 Dec 15:08	Share

Neurizon Receives Additional R&D Tax Incentive Rebate
11 Dec 13:47	Share

Notice of Company Update Webinar
05 Dec 09:29	Share

Section 708A Cleansing Statement
29 Nov 16:17	Share

Application for quotation of securities - NUZ
29 Nov 16:06	Share

Updated Securities Trading Policy
19 Nov 12:13	Share

Correction to text positioning error in announcement
15 Nov 18:30	Share

Neurizon Presents Positive Preclinical Data on NUZ-001
15 Nov 09:59	Share

NUZ-001 Reduces Aggregation of Key ALS Disease Target
15 Nov 09:50	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 12.5¢		Change 0.015(13.6%)		Mkt cap ! $61.53M

Open	High	Low	Value	Volume
12.0¢	13.0¢	12.0¢	$45.40K	368.6K

Buyers (Bids)

No.	Vol.	Price($)
1	457783	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	266325	5

View Market Depth

No.	Vol.	Price($)
1	457783	0.125
2	145584	0.120
1	20000	0.115
3	51250	0.110
7	69842	0.105

Price($)	Vol.	No.
0.130	266325	5
0.135	350000	2
0.140	201859	2
0.145	490000	2
0.150	59760	2

Last trade - 16.10pm 23/04/2025 (20 minute delay)

NUZ (ASX) Chart